ABUS vs ERAS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

ABUS

69.7
AI Score
VS
ABUS Wins

ERAS

45.0
AI Score

Investment Advisor Scores

ABUS

70score
Recommendation
BUY

ERAS

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABUS ERAS Winner
Net Income -33.50M -227.52M ABUS
Operating Income -38.16M -235.53M ABUS
ROE -43.7% -62.9% ABUS
ROA -35.4% -52.3% ABUS
Total Assets 94.62M 435.05M ERAS
Cash 18.01M 42.54M ERAS
Current Ratio 15.73 8.29 ABUS

Relative Price Performance (Last 90 Days)

ABUS 1M: -13.9% · 3M: -4.8% ERAS 1M: -0.9% · 3M: -23.7%

Current Technical Phase

ABUS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.9%), weak momentum, RSI 38

RSI (14): 37.6 · Price: $4.20

ERAS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.0 · Price: $14.39

Fundamentals Snapshot

Metric ABUS ERAS
Market Cap — —
Forward P/E -37.8 -23.1
Trailing P/E 5.3 —
Revenue (TTM) — —
Revenue Growth -0.9% 0.0%
Gross Margin 0.9% —
Operating Margin -5.7% 0.0%
EPS 0.79 -0.95
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ABUS is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.